In The News Posted January 7, 2020 Share Posted January 7, 2020 4D Pharma anuncia la apertura de un estudio que investiga MRx0518 en combinación con radioterapia en pacientes con cáncer pancreático reseccionable LEEDS, Inglaterra, 7 de enero de 2020 /PRNewswire/ -- 4D pharma plc (AIM: DDDD), una compañía farmacéutica que lidera el desarrollo de Live... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.